Procalcitonin testing not impacting antibiotic rx for COPD

Procalcitonin testing not impacting antibiotic rx for COPD

(HealthDay)—Hospital adoption of procalcitonin (PCT) testing has had little impact on antibiotic prescribing for chronic obstructive pulmonary disease (COPD) exacerbations, according to a study published online Aug. 10 in the Annals of the American Thoracic Society.

Peter K. Lindenauer, M.D., from Baystate Medical Center in Springfield, Mass., determined the impact of PCT testing on of patients hospitalized for exacerbations of COPD in routine practice. The authors evaluated data from 505 hospitals (2009 to 2011 and 2013 to 2014).

The researchers found that of 203,177 patients hospitalized for COPD exacerbation in 2013 to 2014, nearly nine out of 10 were treated with antibiotics, while hospital PCT testing rates ranged from 0 to 83 percent. There was a weak negative association between the rate of PCT testing and risk-adjusted rates of antibiotic initiation (P = 0.005), with each 10 point increase in the percentage of patients undergoing PCT testing associated with a 0.7 percent decline in risk-adjusted antibiotic use (P = 0.001). There was not a significant change in antibiotic treatment rates or duration of therapy between hospitals that had adopted PCT testing compared to those that had not, when comparing treatment patterns between 2009 to 2011 and 2013 to 2014.

"As currently implemented, PCT testing appears to have had little impact on decisions to initiate or on duration of treatment for COPD exacerbations," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Procalcitonin testing not impacting antibiotic rx for COPD (2017, August 21) retrieved 29 March 2024 from https://medicalxpress.com/news/2017-08-procalcitonin-impacting-antibiotic-rx-copd.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Early antibiotic treatment for severe COPD symptoms linked with improved outcomes

0 shares

Feedback to editors